March 2017 - BBClist - maillist.psb.ugent.be

3 PhD student vacancies @UAntwerpen on data mining, bioinformatics and epidemiology of Tuberculosis
by Laukens Kris 02 Mar '17

02 Mar '17

Dear colleagues, UAntwerpen has 3 vacancies for PhD students on bioinformatics, large scale data mining and epidemiology of Tuberculosis. Feel free to distribute this among potentially interested participants. PhD in Omics Bioinformatics and/or Systems Biology for Mycobacterium tuberculosis https://www.uantwerpen.be/nl/jobs/vacatures/ap/2017bapfggwef074/ PhD Student in large-scale molecular data mining https://www.uantwerpen.be/nl/jobs/vacatures/ap/2017bapfwetef076/ PhD Student in Epidemiology of Tuberculosis https://www.uantwerpen.be/nl/jobs/vacatures/ap/2017bapfggwef075/ Thank you in advance! warm regards, Kris -- Kris Laukens, PhD Associate professor bioinformatics - biodata mining Advanced Database Research and Modelling (ADReM) Biomedical Informatics Network Antwerpen (biomina) Department of Mathematics and Computer Science University of Antwerp Middelheimlaan 1, G.111 B-2020 Antwerpen, Belgium T +32 (0)3 265 33 10 E kris.laukens(a)uantwerpen.be<mailto:kris.laukens@uantwerpen.be> W www.uantwerpen.be/en/staff/kris-laukens/<http://www.uantwerpen.be/en/staff/kris-laukens/>

1 0

PhD position UGent - UZGent: Analysis of circulating tumour DNA for early detection and selection of cancer patients for precision medicine
by Björn Menten 02 Mar '17

02 Mar '17

Analysis of circulating tumour DNA for early detection and selection of cancer patients for precision medicine Job description You will join a team that focuses on the study of circulating tumor DNA (and RNA) for the diagnosis of cancer and therapeutic stratification for precision medicine (“liquid” biopsy). The development of these liquid biopsies is based on Massively Parallel Sequencing (Next Generation Sequencing) of circulating tumor DNA (and RNA) present in plasma of cancer patients. We will use Shallow Whole Genome Sequencing (for the detection of Copy Number Alterations), as well as targeted sequencing (for the detection of point mutations in many oncogenes, tumor suppressor genes and DNA repair genes). Your task in the team focuses on the development of bioinformatic and statistical tools for the analysis of the Next Generation Sequencing data. Furthermore, you will be intensely involved in the selection of genes for large panels relevant for the development of liquid biopsies. The aim of the project is early diagnosis of cancer, therapeutic stratification for precision medicine, follow-up after therapy, and the detection of potential targets for therapy. The project focuses on lung cancer and lymphoma, but the approach is also promising for other tumor types. The project is a collaboration between the Department of Pathology (Laboratory for Cancer Diagnostics and Pathology), the Center for Medical Genetics, the Department of Thoracic Oncology, the Department of Hematology, and the Center for Molecular Diagnostics Ghent. All these clinical departments and laboratories are located at the campus of Ghent University Hospital. Profile of the candidate ● You hold a master degree in one of the following disciplines: Bioengineering, Biochemistry and Biotechnology, Bioinformatics or an equivalent field. ● You are interested in challenging scientific research. ● You are interested in cancer biology and molecular biological techniques. In close collaboration with the other team members you will try to gain insight in the genetic alterations in tumors, important for the development of diagnostic and prognostic molecular tests on circulating tumor DNA (and RNA). ● You aim is to obtain a PhD degree. ● You have knowledge of bioinformatic tools and in particular of genomics data analysis (e.g. Whole Exome Sequencing, Whole Genome Sequencing, …). ● You have knowledge of commonly used programming languages in bioinformatics, like R, Python and Perl. ● You can work independently, but are also a good team player. ● You are a creative mind and a problem solver. ● You are communicative. ● You hold, or expect to hold by June 2017, a master degree (the latest starting date is August 1, 2017). How to apply? Interested? We are looking forward to receiving your C.V., together with an overview of your study results, a motivation letter and two references. Send your application to katrien.vanbost(a)ugent.be<mailto:katrien.vanbost@ugent.be>. For more information, please contact: Prof. dr. Jo Van Dorpe Department of Pathology - Laboratory for Cancer Diagnostics and Pathology jo.vandorpe(a)uzgent.be<mailto:jo.vandorpe@uzgent.be> T +32 9 332 51 38 Prof. dr. ir. Björn Menten Center for Medical Genetics Ghent bjorn.menten(a)ugent.be<mailto:bjorn.menten@ugent.be> T +32 9 332 52 84 Prof. dr. ir. Kathleen Claes Center for Medical Genetics Ghent kathleen.claes(a)ugent.be<mailto:kathleen.claes@ugent.be> T +32 9 332 24 78

1 0

Post-doctoral position: Analysis of multi-level molecular networks in cancer.
by Francisco Azuaje 02 Mar '17

02 Mar '17

Dear colleague, We are looking for candidates for this position at the Luxembourg Institute of Health (LIH) : https://www.lih.lu/jobs/detail/post-doctoral-researcher-fa0317-12574 (start-date: Before 1st July 2017) Sincerely, Francisco. _________________________________ Francisco Azuaje, PhD Principal Investigator NORLUX Neuro-Oncology Laboratory Department of Oncology Luxembourg Institute of Health 1A-B, rue Thomas Edison, L-1445 Strassen Luxembourg Tel: +352 26970-875 Fax: +352 26970-719 Email: francisco.azuaje(a)lih.lu<mailto:francisco.azuaje@lih.lu> Website: https://www.lih.lu/ [http://files.lih.lu/outlookSignature/lih.jpg] Join us on Facebook and follow our activities on Twitter: https://www.facebook.com/Luxembourg.Institute.of.Health http://twitter.com/LIH_Luxembourg http://www.norlux.lu This message (including any attachments) is intended for the addressee only and may contain confidential and/or privileged information and/or information protected by intellectual property rights. If you have received this message by mistake, please notify the sender by return e-mail and delete this message from your system. You should not use, alter, copy or distribute this message or disclose its contents to anyone. E-mail transmission can not be guaranteed to be secure or error free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. Luxembourg Institute of Health shall not be responsible nor liable for the proper and complete transmission of the information contained in this communication nor for any delay in its receipt or damage to your system.

1 0

ELIXIR-IIB training course on "Computational approaches to the study of protein interactions and rational drug design" - Padova, 10-13 April, 2017
by Alexander Botzki 01 Mar '17

01 Mar '17

COURSE ANNOUNCEMENT Please circulate this email to those who might be interested ELIXIR-IIB, in collaboration with the University of Padova and RGS-Italy, is pleased to inform you that the applications for the upcoming training course on "Computational approaches to the study of protein interactions and rational drug design" are now open. IMPORTANT DATES for this Course: - Deadline for applications: 28th March 2017 - Course date: 10-13 April 2017 Venue: Campus di Biologia e Biomedicina "Fiore di Botta", University of Padova, Via del Pescarotto, 8, Padova, IT Speakers: Prof. Alexandre Bonvin - Faculty of Science, Utrecht University, the Netherlands Dr. Norman Davey - University College Dublin, Dublin, Ireland) Dr. Stefano Forli - Dept. Molecular Biology, The Scripps Research Institute, La Jolla, USA Prof. Stefano Moro - Dept. of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy A maximum of 30 candidates will be accepted in the course. Selection will start on March 10th, 2017 and those with an adequate profile will be accepted immediately, especially if they come from other cities and/or countries (to allow them to find reasonably cheap flight tickets). Course description: This workshop is aimed at students in master degree courses, PhD students and post-doctoral researchers who are working or planning to work in the field of protein interactions from a molecular and structural point of view. In this workshop, participants will familiarise with docking approaches to the study of protein-protein interactions (PPIs) and protein-small molecule interactions. Irreversible binders design using molecular docking and computational methods to rational drug design will be also described, as well as the functional role of the intrinsically disordered proteins. Should you have any question, do not hesitate to contact the ELIXIR-IIB training coordinator, Dr Allegra Via, at allegra.via(a)cnr.it<mailto:allegra.via@cnr.it> or elixir.ita.training(a)gmail.com<mailto:elixir.ita.training@gmail.com>. Full details at: https://elixir-iib-training.github.io/website/2017/04/10/protein-interactio… Best regards, The ELIXIR-IIB Training Team

1 0